IRIS
OFFIDANI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.435
AS - Asia 786
EU - Europa 675
SA - Sud America 208
Continente sconosciuto - Info sul continente non disponibili 85
AF - Africa 65
OC - Oceania 2
Totale 3.256
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.365
IT - Italia 223
VN - Vietnam 210
SG - Singapore 195
BR - Brasile 149
CN - Cina 140
RU - Federazione Russa 127
HK - Hong Kong 106
DE - Germania 70
FR - Francia 52
GB - Regno Unito 35
CI - Costa d'Avorio 32
FI - Finlandia 32
AR - Argentina 27
CA - Canada 27
IN - India 25
IE - Irlanda 24
SE - Svezia 23
UA - Ucraina 19
JP - Giappone 17
TR - Turchia 17
NL - Olanda 15
AT - Austria 13
MX - Messico 13
BD - Bangladesh 12
EC - Ecuador 10
CO - Colombia 9
DK - Danimarca 9
MA - Marocco 9
SA - Arabia Saudita 8
ZA - Sudafrica 8
CR - Costa Rica 7
ID - Indonesia 7
IQ - Iraq 7
UZ - Uzbekistan 7
ES - Italia 6
IL - Israele 5
PK - Pakistan 5
PL - Polonia 5
VE - Venezuela 5
HN - Honduras 4
HU - Ungheria 4
KR - Corea 4
LT - Lituania 4
SN - Senegal 4
SV - El Salvador 4
BE - Belgio 3
CW - ???statistics.table.value.countryCode.CW??? 3
GT - Guatemala 3
JO - Giordania 3
MY - Malesia 3
PR - Porto Rico 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
GR - Grecia 2
HR - Croazia 2
KE - Kenya 2
KZ - Kazakistan 2
NI - Nicaragua 2
NP - Nepal 2
PE - Perù 2
SC - Seychelles 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CD - Congo 1
CH - Svizzera 1
CL - Cile 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
LK - Sri Lanka 1
LU - Lussemburgo 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
TH - Thailandia 1
ZW - Zimbabwe 1
Totale 3.174
Salva come PNG Salva come JPEG
Città #
Ashburn 339
Dallas 133
Singapore 113
Hong Kong 102
San Jose 101
Council Bluffs 97
Ho Chi Minh City 76
Hanoi 48
Boardman 42
The Dalles 37
Los Angeles 36
Abidjan 32
Munich 31
New York 28
Chandler 26
São Paulo 26
Moscow 25
Beijing 24
Dublin 24
Lauterbourg 23
Milan 23
Rome 23
Helsinki 20
Santa Clara 19
Hefei 18
Frankfurt am Main 16
Jacksonville 15
Phoenix 15
Denver 14
Fairfield 14
Wilmington 13
Turin 12
Buffalo 11
Da Nang 11
Nuremberg 11
Orem 11
Seattle 11
Chennai 9
Houston 9
Montreal 9
Turku 9
Brooklyn 8
Mexico City 8
Tokyo 8
Amsterdam 7
Ancona 7
Bologna 7
Guangzhou 7
Bari 6
Chicago 6
Tashkent 6
Woodbridge 6
Cambridge 5
Columbus 5
Falconara Marittima 5
Haiphong 5
Johannesburg 5
Lawrence 5
London 5
Lynnwood 5
Miami 5
North Charleston 5
Princeton 5
San José 5
Toronto 5
Washington 5
Atlanta 4
Bowling Green 4
Brescia 4
Camden 4
Cartagena 4
Dakar 4
Harper Woods 4
Hải Dương 4
Milwaukee 4
Newark 4
Ninh Bình 4
Piscataway 4
Rio de Janeiro 4
Warsaw 4
Ankara 3
Ann Arbor 3
Baghdad 3
Belton 3
Biên Hòa 3
Boston 3
Brussels 3
Buenos Aires 3
Caracas 3
Curitiba 3
Detroit 3
Elk Grove Village 3
Guatemala City 3
Guayaquil 3
Holstebro 3
Huế 3
Islington 3
Magnesia ad Sipylum 3
Manchester 3
Medellín 3
Totale 1.918
Salva come PNG Salva come JPEG
Nome #
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 176
Real‐world assessment of treatment patterns and outcomes in patients with relapsed‐refractory multiple myeloma in an Italian haematological tertiary care centre 157
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma 151
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab‐Refractory Multiple Myeloma Patients: A Multicenter Real‐World Study 150
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 147
Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study 145
Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomidedexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data 141
NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES 135
Current Main Topics in Multiple Myeloma 134
Anticoagulation and vessel recanalization in cirrhotic patients with splanchnic vein thrombosis: A multidisciplinary “real life” experience 133
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 130
Clinical Presentation, Risk Factors and Outcome of Splanchnic Venous Thrombosis: A Report on 305 Cases 124
Frequency and Risk Factors for Venous Thromboembolism Among Patients with Multiple Myeloma or Aggressive Lymphoma: A 6-Year Single Center Retrospective Analysis 120
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report 115
AL amyloidosis: an overview on diagnosis, staging system, and treatment 115
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment 114
Infection events in patients with newly diagnosed multiple myeloma with anti-CD38 monoclonal antibody-based first line regimens: A multicentric Italian experience 113
Long-Term Survival with Multiple Myeloma: An Italian Experience 111
Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety 110
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy 108
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab‐, Elotuzumab‐, and Carfilzomib‐Based Triplet Regimens: A Multicenter Real‐World Analysis of 635 Patients 105
Belantamab Mafodotin: From Clinical Trials Data to Real-Life Experiences 104
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study 104
The Challenging Approach to Multiple Myeloma: From Disease Diagnosis and Monitoring to Complications Management 91
Cytogenetic Features and Their Implications in Clinical Practice: A Real-World Analysis of a Large Cohort of Multiple Myeloma Patients 81
Sequential Bispecific Antibodies in Functional and Clinical High Risk Multiple Myeloma, Manifesting with Extramedullary Disease at Relapse: A Case Report 77
Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy 65
Totale 3.256
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.955
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.955
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202224 0 0 0 0 0 1 5 3 1 2 6 6
2022/202387 5 11 7 3 4 11 0 4 18 0 24 0
2023/2024182 15 5 8 11 22 18 4 5 9 7 23 55
2024/2025549 40 27 21 6 12 33 40 25 130 80 57 78
2025/20261.868 145 135 169 174 188 179 367 145 107 152 61 46
2026/2027419 70 67 79 184 19 0 0 0 0 0 0 0
Totale 3.256